慢性髓性白血病患者CD34+细胞BCR-ABL融合基因的检测意义

慢性髓性白血病(CML)是一种起源于造血干细胞的恶性克隆性疾病。其特征性标志是Ph染色体及BCR—ABL融合基因。酪氨酸激酶抑制剂(TKI)作为CML患者靶向治疗药物,极大程度提高了CML患者的临床疗效,现已成为CML临床一线治疗药物。...

Full description

Saved in:
Bibliographic Details
Published in中华血液学杂志 Vol. 38; no. 2; pp. 164 - 166
Main Author 马轶轩 王璐 米瑞华 王献伟 吕晓东 范瑞华 魏旭东
Format Journal Article
LanguageChinese
Published 450008,郑州大学附属肿瘤医院(河南省肿瘤医院)血液科 2017
Subjects
Online AccessGet full text
ISSN0253-2727
DOI10.3760/cma.j.issn.0253-2727.2017.02.016

Cover

Abstract 慢性髓性白血病(CML)是一种起源于造血干细胞的恶性克隆性疾病。其特征性标志是Ph染色体及BCR—ABL融合基因。酪氨酸激酶抑制剂(TKI)作为CML患者靶向治疗药物,极大程度提高了CML患者的临床疗效,现已成为CML临床一线治疗药物。
AbstractList @@
慢性髓性白血病(CML)是一种起源于造血干细胞的恶性克隆性疾病。其特征性标志是Ph染色体及BCR—ABL融合基因。酪氨酸激酶抑制剂(TKI)作为CML患者靶向治疗药物,极大程度提高了CML患者的临床疗效,现已成为CML临床一线治疗药物。
Author 马轶轩 王璐 米瑞华 王献伟 吕晓东 范瑞华 魏旭东
AuthorAffiliation 郑州大学附属肿瘤医院河南省肿瘤医院血液科,450008
AuthorAffiliation_xml – name: 450008,郑州大学附属肿瘤医院(河南省肿瘤医院)血液科
Author_FL Lyu Xiaodong
Fan Ruihua
Wei Xudong
Mi Ruihua
Wang Lu
Ma Yixuan
Wang Xianwei
Author_FL_xml – sequence: 1
  fullname: Ma Yixuan
– sequence: 2
  fullname: Wang Lu
– sequence: 3
  fullname: Mi Ruihua
– sequence: 4
  fullname: Wang Xianwei
– sequence: 5
  fullname: Lyu Xiaodong
– sequence: 6
  fullname: Fan Ruihua
– sequence: 7
  fullname: Wei Xudong
Author_xml – sequence: 1
  fullname: 马轶轩 王璐 米瑞华 王献伟 吕晓东 范瑞华 魏旭东
BookMark eNo9j0tLw0AUhWdRwbb6J1yIm8R5JDPJso1vCoJ0XybTpA_sVBvE1lWorShFFFyICvXRhQvXLnz9G5vElX_BkYqbc7j3fpzDzYCUbEoPgAUEdcIoXBQNrtf1WhBIHWKTaJhhpmOImBp1iGgKpP_30yATBHUIDXU30mAj6j9E4ePX04XS-OojuQ_jy37UHSVh31kixvf7IH47Sg6HeWdLy-ULyfB0fH48vn0d39zF171oFEbPg6h39vlyMgOmfL4deLN_ngXFleWis6YVNlfXnVxBE6ZFNY480xaui8uGZ5aJZVs-I9ywsEHLpokI8yziEtuDUFBKfRsKF2MCGbUNLBCDJAvmJ7H7XPpcVkr15l5LqsLSQbXdaf--DZVQBc5NQFFtyspuTaE7rVqDtzolyhBGkKi0H9tWcX0
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3760/cma.j.issn.0253-2727.2017.02.016
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Significance of BCR-ABL fusion gene detection in CD34+ cells of chronic myelogenous leukemia patients
DocumentTitle_FL Significance of BCR-ABL fusion gene detection in CD34 + cells of chronic myelogenous leukemia patients
EndPage 166
ExternalDocumentID zhxyx201702016
671210370
GrantInformation_xml – fundername: 国家自然科学基金
  funderid: (81170520)
GroupedDBID ---
-05
2B.
2C~
2RA
92F
92I
92L
ACGFS
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CIEJG
CQIGP
CW9
F5P
OK1
RPM
TCJ
TGQ
U1G
U5O
W91
~WA
4A8
93N
ABJNI
PSX
ID FETCH-LOGICAL-c586-a1e59cbb2d4e5d3898f73a48246d55137e83b39e00c666f90cb223076942c1703
ISSN 0253-2727
IngestDate Thu May 29 04:00:17 EDT 2025
Wed Feb 14 10:18:50 EST 2024
IsPeerReviewed false
IsScholarly true
Issue 2
Keywords @@
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c586-a1e59cbb2d4e5d3898f73a48246d55137e83b39e00c666f90cb223076942c1703
Notes 12-1090/R
Ma Yixu- an, Wang Lu, Mi Ruihua, Wang Xianwei, Lyu Xiaodong, Fan Ruihua, Wei Xudong( Department of Hematolo- gy, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China. )
PageCount 3
ParticipantIDs wanfang_journals_zhxyx201702016
chongqing_primary_671210370
PublicationCentury 2000
PublicationDate 2017
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017
PublicationDecade 2010
PublicationTitle 中华血液学杂志
PublicationTitleAlternate Chinese Journal of Hematology
PublicationTitle_FL Chinese Journal of Hematology
PublicationYear 2017
Publisher 450008,郑州大学附属肿瘤医院(河南省肿瘤医院)血液科
Publisher_xml – name: 450008,郑州大学附属肿瘤医院(河南省肿瘤医院)血液科
SSID ssj0042014
ssib051368330
ssib017477332
ssib001103535
ssib058574913
Score 2.093334
Snippet 慢性髓性白血病(CML)是一种起源于造血干细胞的恶性克隆性疾病。其特征性标志是Ph染色体及BCR—ABL融合基因。酪氨酸激酶抑制剂(TKI)作为CML患者靶向治疗药物,极大程度提高了CML患者的临床疗效,现已成为CML临床一线治疗药物。
@@
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 164
SubjectTerms BCR-ABL融合基因
CD34+细胞
恶性克隆性疾病
慢性髓性白血病
检测
白血病患者
酪氨酸激酶抑制剂
靶向治疗药物
Title 慢性髓性白血病患者CD34+细胞BCR-ABL融合基因的检测意义
URI http://lib.cqvip.com/qk/93752X/201702/671210370.html
https://d.wanfangdata.com.cn/periodical/zhxyx201702016
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NaxQxFB_aCuJFFBVr_ejBgCBTJ8lMPo6T6SxF0INU6G2ZmZ1pEdz60ULtadFWFBEFD6JC_ejBg2cPKv4rnuzu-l_4XmZ2O5ZCa2EZsi_Jyy_vTTbvZZMXx7moKEzcNE9d0VLgoGQ8d7XKPTejeZJoX3Ke4zrkteti5qZ_dS6YGxn9Vdu1tLyUTmWru54rOYhWgQZ6xVOy_6HZIVMgQBr0C0_QMDz3pWMSC6ICEjKb8EgoSaxJaIjmNYokWhMzTWJFQopEpEisiGUYCTlmAV0F0TT3CTNYwhiihM3gRMcmuuGGuDVCwReigFlANNRQNtEgJrQJQ8KSfUiUj-yBNzYoiAmIMrZBMF4bJPaJ0aS81mdgG1siYLTMoQkV1yADB_gwzIICoUCKnkb4QDENoofzqRUBfCKsDd02okqEeruIRO7KdlQzor16jqHEcJtDsbMDMLtWVhEJYws8AjHUl1DKs6L2dffxOggFLzNCQ3FSC1pW3EPfqmnYMY36QvEFCEVbKUA_oZOISWF5xBShisrC8AIwZWXELHSLWJeqj8BX2B8HvZu4JWIrbzqr5gsWcJfJMtTCYHLjqjaIWW2momXw-MrooeXVNzvnU9wxBYMgu51M3bKNTA0bwV2R0oa7pTtCmVvjaHVh5cEKFgF3hIpR5xCTkgY7VtPA9OTBtrkeUC4U33ZnwZOVvv0XvbSsfGBlw8ENMBx2LlUgr-wFEUOnLCy25--CQWjP57WLpD1fMyVnjzlHKx9wMiwH9HFnZHXhhDPTXf_U7Xz-8-UVPHtvfvY_dnqv17sPN_uddRyWl3s_HvcfbVQDsb_xfOvlk63337fefei9Xetudrpfn3XXXvz-9vSkM9uIZ6MZt7rmxM0CJdyE5oHO0pS1_Dxogf-gCskTXzFftPD2JZkrnnKde14mhCi0l6UMT28I7bMM5MtPOWPtxXZ-2pmkoiWLjAda0BzcnFy1cpa0qFckhacLycadiaEQmnfKaDZNITGGIJfeuHOhEkuz-o273_xXjWf2LDHhHMF0uUZ51hlburecnwOrfSk9b1X_F0YHrdc
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%85%A2%E6%80%A7%E9%AB%93%E6%80%A7%E7%99%BD%E8%A1%80%E7%97%85%E6%82%A3%E8%80%85CD34%2B%E7%BB%86%E8%83%9EBCR-ABL%E8%9E%8D%E5%90%88%E5%9F%BA%E5%9B%A0%E7%9A%84%E6%A3%80%E6%B5%8B%E6%84%8F%E4%B9%89&rft.jtitle=%E4%B8%AD%E5%8D%8E%E8%A1%80%E6%B6%B2%E5%AD%A6%E6%9D%82%E5%BF%97&rft.au=%E9%A9%AC%E8%BD%B6%E8%BD%A9&rft.au=%E7%8E%8B%E7%92%90&rft.au=%E7%B1%B3%E7%91%9E%E5%8D%8E&rft.au=%E7%8E%8B%E7%8C%AE%E4%BC%9F&rft.date=2017&rft.pub=450008%2C%E9%83%91%E5%B7%9E%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E8%82%BF%E7%98%A4%E5%8C%BB%E9%99%A2%28%E6%B2%B3%E5%8D%97%E7%9C%81%E8%82%BF%E7%98%A4%E5%8C%BB%E9%99%A2%29%E8%A1%80%E6%B6%B2%E7%A7%91&rft.issn=0253-2727&rft.volume=38&rft.issue=2&rft.spage=164&rft.epage=166&rft_id=info:doi/10.3760%2Fcma.j.issn.0253-2727.2017.02.016&rft.externalDocID=zhxyx201702016
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F93752X%2F93752X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhxyx%2Fzhxyx.jpg